QuidelOrtho Corporation QDEL recently announced that it has been granted a CLIA Waiver by the FDA, which applies to its new Sofia 2 SARS Antigen+ FIA (fluorescent immunoassay). The Sofia 2 SARS ...
The potential for IgM cross-reactivity with rheumatoid factor–positive serum samples was observed in blood tests used to detect IgM SARS-CoV-2 by means of gold immunochromatographic and enzyme-linked ...
Federal health authorities have authorized the first coronavirus antigen point-of-care test. The Food and Drug Administration on Friday issued emergency use authorization for the Sofia 2 SARS Antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results